Medidata Solutions, Inc. (MDSO): Price and Financial Metrics
MDSO Stock Summary
- MDSO's current price/earnings ratio is 130.37, which is higher than 95.42% of US stocks with positive earnings.
- The price/operating cash flow metric for NA is higher than 94.83% of stocks in our set with a positive cash flow.
- With a year-over-year growth in debt of -48.96%, NA's debt growth rate surpasses merely 6.3% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to NA are SMTC, FLGT, CHRS, SEDG, and QLYS.
MDSO Stock Price Chart Interactive Chart >
MDSO Price/Volume Stats
|Current price||$92.22||52-week high||$98.60|
|Prev. close||$92.24||52-week low||$60.10|
|Day high||$92.26||Avg. volume||978,810|
|50-day MA||$91.72||Dividend yield||N/A|
|200-day MA||$85.43||Market Cap||5.76B|
Medidata Solutions, Inc. (MDSO) Company Bio
Medidata Solutions is a provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The company was founded in 1999 and is based in New York, New York.